Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation

BACKGROUND: Among the currently available prognostic models for diffuse large B-cell lymphoma (DLBCL), we investigated to determine which is most adoptable for DLBCL patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) followed by upfront autologous st...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hong Ghi, Kim, Sung-Yong, Kim, Inho, Kim, Yeo-Kyeoung, Kim, Jeong-A, Kim, Yang Soo, Lee, Ho Sup, Park, Jinny, Kim, Seok Jin, Shim, Hyeok, Eom, Hyeon Seok, Park, Byeong-Bae, Lee, Junglim, Park, Sung Kyu, Cheong, June-Won, Park, Keon Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595582/
https://www.ncbi.nlm.nih.gov/pubmed/26457283
http://dx.doi.org/10.5045/br.2015.50.3.160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595582/
https://www.ncbi.nlm.nih.gov/pubmed/26457283
http://dx.doi.org/10.5045/br.2015.50.3.160

Ejemplares similares